appScorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Lupin Ltd
LUPIN
Price Chart
Scorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Lupin declines 0.98% as Sensex slides
18 hours ago•Economic Times
Lupin shares decline 0.69% as Sensex climbs
1 day ago•Economic Times
Lupin declines 0.51% as Sensex slides
2 days ago•Economic Times
Trade setup for today: Top 15 things to know before the opening bell
3 days ago•Moneycontrol
Tata Motors, Lupin, Titan among 139 NSE stocks to hit 52-week highs; 16 touch 52-week lows | The Financial Express
3 days ago•Financial Express
Lupin shares hit 52-week high after launch of HIV drug Darunavir in US
3 days ago•Economic Times
Lupin shares hit 52-week high after launch of Darunavir tablets
3 days ago•Moneycontrol
Stocks to watch today — June 5, 2023
3 days ago•The Hindu Businessline
Stocks to Watch: Tata Motors, Oil Stocks, NTPC, Wipro, Lupin, Tech M, and Others
3 days ago•News18
Stocks To Watch on 5 June, 2023: Vedanta, Lupin, SBI Life, TechM, Bajaj Finance, Bajaj Finserv, Indian Oil, NTPC | The Financial Express
3 days ago•Financial Express
Recent EventsAll events
Press Release
Lupin Limited has informed the Exchange regarding a press release dated Jun 03, 2023, titled "Lupin Launches Darunavir Tablets in the United States.". | Download
Lupin Limited has informed the Exchange regarding a press release dated Jun 03, 2023, titled "Lupin Launches Darunavir Tablets in the United States.". | Download
Press Release
Lupin Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "Lupin Receives Approval from U.S. FDA for Diazepam Rectal Gel.". | Download
Lupin Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "Lupin Receives Approval from U.S. FDA for Diazepam Rectal Gel.". | Download
Cash Dividend
Final • Div/Share: ₹ 4
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant